The Glucose Never Lies® Podcast

Episode 42: DICE 2026 - The Highlights

Suggest guests or get in contact [https://www.buzzsprout.com/2451357/fan_mail/new] Suggest guests or get in contact [https://www.buzzsprout.com/2451357/fan_mail/new] John Pemberton was at Croke Park on 21 May for DICE — Diabetes Ireland Conference and Exhibition — Ireland's premier annual event for healthcare professionals working in diabetes. The day also saw the launch of the landmark National Policy and Services Review for diabetes in Ireland. John grabbed a microphone and seven conversations. This episode is all of them. Anjanee Kohli is Co-Director and Creative Director of The Glucose Never Lies® and the host for this episode. John Pemberton is founder of The Glucose Never Lies® and a paediatric diabetes dietitian at Birmingham Women's and Children's NHS Foundation Trust; he is also a person living with T1D. This episode reflects the independent views of both. This episode covers: * Sinead Powell (Education and Support Coordinator, Diabetes Ireland): the COPE programme, emotional wellbeing in type 2 diabetes, language, stigma, and why information alone is never enough * Kathy Breen (Clinical Specialist Dietitian and Dietetic Lead, National Diabetes Programme): what Language Matters looks like in practice, person-first language, and its inclusion in the new national strategy * Kate Gaievska (Clinical Manager for Advocacy and Research, Diabetes Ireland): why adult diabetes psychology services in Ireland are effectively non-existent, what the strategy commits to, and the long road of implementation * Professor Fidelma Dunne (University of Galway / National Clinical Trials Network in Diabetes): how clinical trials get funded, why real-world data matters, and why research is not the icing on the cake * Christine Newman (Diabetes Consultant, Galway): hybrid closed-loop in pregnancy, CGM for type 2, and the case for free glucose strips for gestational diabetes * Professor Derek O'Keefe (Consultant Physician and Professor of Medical Device Technology, UHG): Mochara, a bounded AI education tool that matched nurse and doctor performance in trials, ambient clinical documentation, intelligent dynamic triage, and what multimodal AI means for diabetes care * Dr Tomas Griffin (Consultant Diabetologist, Galway / DTN Ireland): what the strategy means for pump access, the DTN Ireland roadshow, and why every tier of hospital in Ireland is now starting pump therapy Show notes: https://theglucoseneverlies.com/ Have more questions? Ask GNL Grace, a diabetes educational adviser built by a team with skin in the game. Grace gets you 80% of the way there with 20% of the effort; the final 20% takes self-discovery, guided by human expertise and trial-and-error learning. https://theglucoseneverlies.com/gnl-grace/ Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/jspfree2 [https://www.buymeacoffee.com/jspfree2] Enquiries Collaboration: John Pemberton — john@theglucoseneverlies.com Creatives: Anjanee Kohli — anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ [https://theglucoseneverlies.com/] Instagram: https://www.instagram.com/theglucoseneverlies [https://www.instagram.com/theglucoseneverlies] LinkedIn: https://www.linkedin.com/company/theglucoseneverlies [https://www.linkedin.com/company/theglucoseneverlies] LinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ [https://www.linkedin.com/in/john-pemberton-587104361/] X: https://twitter.com/GlucoseNLies [https://twitter.com/GlucoseNLies] Disclaimer This content is for informational purposes only and does not constitute medical advice. © The Glucose Never Lies Ltd. All rights reserved.

Ep 41: CGM Series Round-Up, Grace Update and John on Diabetech

Suggest guests or get in contact [https://www.buzzsprout.com/2451357/fan_mail/new] Every few months, The Glucose Never Lies stops and takes stock. No single guest, no single topic: three CGM Series episodes have landed since the last round-up, Grace has a new model, and John has appeared on two podcasts that are not his own. This episode covers all of it. Anjanee Kohli is Co-Director and Creative Director of The Glucose Never Lies® and the host for this episode. John Pemberton is founder of The Glucose Never Lies® and a paediatric diabetes dietitian at Birmingham Women's and Children's NHS Foundation Trust; he is also a person living with T1D. This episode reflects the independent views of both. This episode covers: - CGM Series catch-up: episodes 38, 39, and 40 in one conversation - The IFCC glucose stress test: what it measures, the CE-versus-FDA accuracy gap, and the car crash analogy for insulin-dosing sensors - The MDI generation gap: why people on injections have had one generation of CGM while pump users have had five - What 17 early adopters actually reported about Night Low Predict and Glucose Predict on the Accu-Chek SmartGuide - Grace's new model: free for people with T1D, HCP at £25 a month, Max at £60 a month, plus-one at £5 a month - The near-bankruptcy moment: flat architecture to wiki retrieval layer, cost reduced to roughly five per cent - Why Grace has no memory by design: the deliberate reasoning behind a deliberate constraint - John on Diabetech (Gary Shiner's show, hosted by Justin): CGM international testing standards - John on Tomorrow's Medicine with Arseniy Arsentyev: how Grace was built, the antibody result that started it, and what nearly ended it - AI and healthcare work: the people who adapt, the people who hide behind procedure, and what cannot be automated Show notes: https://theglucoseneverlies.com/episode-41-cgm-series-grace-diabetech/ Before this episode, John appeared on: Diabetech (Gary Shiner's show, hosted by Justin): https://youtu.be/6sxM1HOxcP4?si=2B3lHzyjSBgPKYfb Tomorrow's Medicine with Arseniy Arsentyev: https://youtu.be/60MZGAk86NY?si=l3oF1J37EiI7fcCE Have more questions? Ask GNL Grace, a diabetes educational advisor built by a team with skin in the game. Grace gets you 80% of the way there with 20% of the effort; the final 20% takes self-discovery, guided by human expertise and trial-and-error learning. https://theglucoseneverlies.com/gnl-grace/ --- Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/gnlfree Enquiries Collaboration: John Pemberton, john@theglucoseneverlies.com Creatives: Anjanee Kohli, anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ Instagram: https://www.instagram.com/theglucoseneverlies LinkedIn: https://www.linkedin.com/company/theglucoseneverlies LinkedIn John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ LinkedIn Anjanee Kohli: https://www.linkedin.com/in/anjanee-kohli-chohan-1b22a217b/ Instagram Anjanee Kohli: https://www.instagram.com/anjanee.dietitian X: https://twitter.com/GlucoseNLies Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/jspfree2 [https://www.buymeacoffee.com/jspfree2] Enquiries Collaboration: John Pemberton — john@theglucoseneverlies.com Creatives: Anjanee Kohli — anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ [https://theglucoseneverlies.com/] Instagram: https://www.instagram.com/theglucoseneverlies [https://www.instagram.com/theglucoseneverlies] LinkedIn: https://www.linkedin.com/company/theglucoseneverlies [https://www.linkedin.com/company/theglucoseneverlies] LinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ [https://www.linkedin.com/in/john-pemberton-587104361/] X: https://twitter.com/GlucoseNLies [https://twitter.com/GlucoseNLies] Disclaimer This content is for informational purposes only and does not constitute medical advice. © The Glucose Never Lies Ltd. All rights reserved.

Episode 40 - Accu-Chek SmartGuide: CGM Generation 2.0 for MDI | Amy Jolley | GNL Podcast

Suggest guests or get in contact [https://www.buzzsprout.com/2451357/fan_mail/new] People on MDI have had one generation of CGM technology: a sensor that tells you what your glucose is doing now, with a 15-minute trend arrow. While pump users have moved through five iterations, injection users have been waiting. The Accu-Chek SmartGuide is the first attempt at a second generation - and this episode asks whether it delivers. Amy Jolley is a Highly Specialised Dietitian, Lead Educator at the Diabetes Technology Network UK, and Lead for the Young Adult and Transition Service at Salford NHS Foundation Trust. This episode is not endorsed by Roche Diagnostics, but the experience of a healthcare professional's experience of putting 17 people onto the SmartGuide in one week, running group onboarding sessions, and asking them to come back and tell her what actually happened. Her host, John Pemberton, is founder of The Glucose Never Lies® and a person living with T1D.  This episode covers: - Why MDI has been stuck at Generation 1 while pump technology moved through five iterations - Night Low Predict: RAG ratings, first-half versus second-half of the night, and how to teach it - Glucose Predict: the 45-minute action window versus the two-hour awareness window - What 17 early adopters actually reported back - How the 45-minute look ahead reduces the rage bolus - Why calibration is an educational opportunity, not a drawback - CGM market saturation and the DTN quality standard - The DTN Competency Assessment Framework: four tiers, self-assessment, a training passport for clinicians - GNL Grace in clinical practice: Amy's feedback from a specialist service supporting 700 AID users Show notes: https://theglucoseneverlies.com/accu-chek-smartguide-mdi-cgm-series/ Have more questions? Ask GNL Grace, a diabetes educational advisor built by a team with skin in the game. Grace gets you 80% of the way there with 20% of the effort; the final 20% takes self-discovery, guided by human expertise and trial-and-error learning. https://theglucoseneverlies.com/gnl-grace/ --- Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/gnlfree Enquiries Collaboration: John Pemberton, john@theglucoseneverlies.com Creatives: Anjanee Kohli, anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ Instagram: https://www.instagram.com/theglucoseneverlies LinkedIn: https://www.linkedin.com/company/theglucoseneverlies LinkedIn John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ LinkedIn Anjanee Kohli: https://www.linkedin.com/in/anjanee-kohli-chohan-1b22a217b/ Instagram Anjanee Kohli: https://www.instagram.com/anjanee.dietitian X: https://twitter.com/GlucoseNLies Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/jspfree2 [https://www.buymeacoffee.com/jspfree2] Enquiries Collaboration: John Pemberton — john@theglucoseneverlies.com Creatives: Anjanee Kohli — anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ [https://theglucoseneverlies.com/] Instagram: https://www.instagram.com/theglucoseneverlies [https://www.instagram.com/theglucoseneverlies] LinkedIn: https://www.linkedin.com/company/theglucoseneverlies [https://www.linkedin.com/company/theglucoseneverlies] LinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ [https://www.linkedin.com/in/john-pemberton-587104361/] X: https://twitter.com/GlucoseNLies [https://twitter.com/GlucoseNLies] Disclaimer This content is for informational purposes only and does not constitute medical advice. © The Glucose Never Lies Ltd. All rights reserved.

Episode 39: Abbott FreeStyle Libre - Accuracy, Simplicity and What's Next

Suggest guests or get in contact [https://www.buzzsprout.com/2451357/fan_mail/new] Michael Skarlatos from Abbott UK Medical Affairs joins John Pemberton for the second manufacturer episode of the CGM Series. A former diabetes specialist dietitian at University Hospitals of Leicester, Michael brings real clinical experience to an honest breakdown of the FreeStyle Libre 2 Plus and 3 Plus. This episode covers: - Why Abbott accuracy data qualifies these sensors for insulin dosing: ICGM approved, 20/20 performance ~95-96%, outside-40/40 error rate 0.2% - What 70% smaller means in practice: form factor, stigma, and the all-in-one applicator on Libre 3 Plus - Pump integrations now and the roadmap: CamAPS FX, Omnipod 5, and what is coming - Libreview: why Abbott moved off Glooko and what population health management enables - Libreview Pro in SystmOne and EMIS with SNOMED-coded CGM metrics - A critical data nuance: glucose measured every minute on the patient app but recorded every 5 minutes in clinical downloads - Continuous ketone monitoring: what Abbott has in development and who benefits most CHAPTERS 00:00 Introduction and CGM Series overview 00:57 Michaels background and Leicester NHS Trust 02:25 Moving from NHS to Abbott Medical Affairs 03:27 Accuracy credentials: ICGM approval and 20/20 performance 05:44 FreeStyle Libre 3 Plus: size and form factor 09:25 Pump integrations: CamAPS FX, Omnipod 5, and the roadmap 10:19 ICGM interoperability: US vs CE marking in Europe 12:05 Fifteen-day wear period 12:28 Abbott market history: free samples and patient-led adoption 14:04 Simplicity of onboarding and multi-language support 16:58 Starter clinics: taking onboarding off the HCP 19:33 Libreview and population health management 23:21 EHR integration, SNOMED codes, and QOF implications 25:46 Practical tips: Bluetooth connectivity and the app cache 29:23 Minute-by-minute data vs five-minute trend recording 30:58 Low glucose event thresholds and hypo underreporting 31:42 Continuous ketone monitoring: what is coming from Abbott 37:52 CGM beyond type 1 and patient advocacy 40:17 Closing thoughts LINKS Show notes: https://theglucoseneverlies.com/episode-38-freestyle-libre-abbott/ YouTube: https://youtu.be/IW1sa5APHU8 CGM Series: https://theglucoseneverlies.com/10-13-cgm-series/ GNL Explorers: https://theglucoseneverlies.com/gnl-grace/ Buzzsprout: https://www.buzzsprout.com/2451357/18982022 Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-glucose-never-lies/id1795741144 Spotify: https://open.spotify.com/show/2MlGlz2G8LsbDnuGtAh77W This content is for educational exploration only. Not medical advice. Support GNL: https://buy.stripe.com/9B63cx4UO3KEdKC0Sp7Re00 [https://buy.stripe.com/9B63cx4UO3KEdKC0Sp7Re00] The Glucose Never Lies® is a registered trademark of The GNL Ltd. Company No. 16733595. UK VAT No. GB 516 3272 08. Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/jspfree2 [https://www.buymeacoffee.com/jspfree2] Enquiries Collaboration: John Pemberton — john@theglucoseneverlies.com Creatives: Anjanee Kohli — anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ [https://theglucoseneverlies.com/] Instagram: https://www.instagram.com/theglucoseneverlies [https://www.instagram.com/theglucoseneverlies] LinkedIn: https://www.linkedin.com/company/theglucoseneverlies [https://www.linkedin.com/company/theglucoseneverlies] LinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ [https://www.linkedin.com/in/john-pemberton-587104361/] X: https://twitter.com/GlucoseNLies [https://twitter.com/GlucoseNLies] Disclaimer This content is for informational purposes only and does not constitute medical advice. © The Glucose Never Lies Ltd. All rights reserved.

Episode 38: Q1 2026 Quarterly Review, GNL Grace, the Explorers, and What Changed

Suggest guests or get in contact [https://www.buzzsprout.com/2451357/fan_mail/new] Three months ago, GNL was a website full of excellent content that was genuinely hard to find. In Episode 38, John Pemberton and Creative Director Anjanee Kohli talk through what happened next: a complete website rebuild, five interactive explorers, the launch of GNL Grace, real-world validation on 1.5 million patient days, and what the Robin Hood model of type 1 diabetes education actually means. In this episode: * CGM guide update and the five-out-of-five accuracy chart * How the five GNL Explorers work and how clinicians are using them in practice * GNL Grace: a bounded AI educational advisor built on 2,000 curated citations * Three Grace tiers: Basic (free), Pro (30 queries/month for subscribers), Max (manuscript-grade output) * The Robin Hood model: industry grants fund free education for everyone * Real-world validation: 33 assessments on 1.5 million patient days * Why the skill of the future in healthcare is compassion, not knowledge * Phil Hayes joining as Technical Director * GNL merch and the Diabetes UK giveaway Chapters: * 00:00 Introduction * 01:55 GNL Grace announcement * 02:32 CGM guide and accuracy chart * 05:30 Phil Hayes and the explorer infrastructure * 09:40 GNL Grace: the six-layer bounded AI * 10:50 Grace tiers and the Robin Hood model * 13:31 Grace Max: manuscript-grade output * 17:31 Real-world validation on 1.5 million patient days * 19:58 The skill of the future is compassion * 30:09 What went wrong and lessons learned * 35:06 GNL merch * 36:10 Closing Links: * Show notes: theglucoseneverlies.com/episode-38-quarterly-review [https://www.theglucoseneverlies.com/episode-38-quarterly-review/] * GNL Grace: theglucoseneverlies.com/gnl-grace [https://www.theglucoseneverlies.com/gnl-grace/] * GNL Explorers: theglucoseneverlies.com/gnl-explorers [https://www.theglucoseneverlies.com/gnl-grace/] * CGM Series hub: theglucoseneverlies.com/10-13-cgm-series [https://www.theglucoseneverlies.com/10-13-cgm-series/] Host: John Pemberton. Director of Creativity: Anjanee Kohli. This content is for educational exploration only. It is not medical advice and cannot replace individual clinical guidance from your diabetes care team. Support GNL: https://buy.stripe.com/9B63cx4UO3KEdKC0Sp7Re00 [https://buy.stripe.com/9B63cx4UO3KEdKC0Sp7Re00] The Glucose Never Lies® is a registered trademark of The GNL Ltd. Company No. 16733595. UK VAT No. GB 516 3272 08. Disclaimer This podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care. The Glucose Never Lies® is independent by design We do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider: Buying the GNL a Coffee: https://www.buymeacoffee.com/jspfree2 [https://www.buymeacoffee.com/jspfree2] Enquiries Collaboration: John Pemberton — john@theglucoseneverlies.com Creatives: Anjanee Kohli — anj@theglucoseneverlies.com Follow The Glucose Never Lies® Website: https://theglucoseneverlies.com/ [https://theglucoseneverlies.com/] Instagram: https://www.instagram.com/theglucoseneverlies [https://www.instagram.com/theglucoseneverlies] LinkedIn: https://www.linkedin.com/company/theglucoseneverlies [https://www.linkedin.com/company/theglucoseneverlies] LinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/ [https://www.linkedin.com/in/john-pemberton-587104361/] X: https://twitter.com/GlucoseNLies [https://twitter.com/GlucoseNLies] Disclaimer This content is for informational purposes only and does not constitute medical advice. © The Glucose Never Lies Ltd. All rights reserved.